Epidermoid cancers of the anal canal: Current treatment

Clinics in Colon and Rectal Surgery

Volumn 22, Issue 2, 2009, Pages 77-83

  Blumetti, Jennifer ^a   Bastawrous, Amir L ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

Anal canal malignancy; Chemoradiation; Epidermoid carcinoma; Nigro protocol

Indexed keywords

EID: 67749108305     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0029-1223838     Document Type: Article

References (38)

1. Mahmoud NN, Madoff RD. Investigation and management of malignant anal-canal tumours. In: Beynon J, Carr ND, eds. Progress in Colorectal Surgery. New York: Springer-Verlag; 2005:115-134
2. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999;85(8):1686-1693
3. Whiteford MH, Stevens KR Jr, Oh S, Deveney KE. The evolving treatment of anal cancer: how are we doing? Arch Surg 2001;136(8):886-891
4. Wong S, Gibbs P, Chao M, et al. Carcinoma of the anal canal: a local experience and review of the literature. ANZ J Surg 2004;74(7):541-546
5. Lopez MJ, Myerson RJ, Shapiro SJ, et al. Squamous cell carcinoma of the anal canal. Am J Surg 1991;162(6):580-584
6. Skibber JM, Eng C. Colon, rectal and anal cancer management. In: Chang AS, Ganz PA, Hayes DF, et al, eds. Oncology, An Evidence Based Approach. New York: Springer-Verlag; 2006:704-732
7. Salmon RJ, Fenton J, Asselain B, et al. Treatment of epidermoid anal canal cancer. Am J Surg 1984;147(1):43-48
8. Mendenhall WM, Sombeck MD, Speer TW, Marsh RD, Carroll RR, Copeland EM III. Current management of squamous cell carcinoma of the anal canal. Surg Oncol 1994; 3(3):135-146
9. Oehler-Jänne C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol 2008;26(15):2550-2557
10. Welton ML, Varma MG. Anal cancer. In: Wolff BG, Fleshman JW, Beck DE, et al, eds. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer-Verlag; 2007:482-500
11. Golden GT, Horsley JS III. Surgical management of epidermoid carcinoma of the anus. Am J Surg 1976;131(3): 275-280
12. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report 1974. Dis Colon Rectum 1993;36:709-711
13. Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981;24(2):73-75
14. Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983;51(10):1826-1829
15. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348 (9034):1049-1054
16. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15(5):2040-2049
17. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14(9):2527-2539
18. Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IHF. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 2008;48(9):1742-1751
19. Gretschel S, Warnick P, Bembenek A, et al. Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canal. Eur J Surg Oncol 2008;34(8): 890-894
20. Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007;25(29):4581-4586
21. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008;299(16):1914-1921
22. Glynne-Jones R, Meadows H, Wan S, et al; National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group. EXTRA - a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 2008;72(1):119-126
23. James R, Meadows H, Wan S. ACT II: the second UK phase III anal cancer trial. Clin Oncol (Royal College of Radiologists) Editorial 2008;17:364-366
24. Glynne-Jones R, Mawdsley S. Anal cancer: the end of the road for neoadjuvant chemoradiotherapy? J Clin Oncol 2008; 26(22):3669-3671
25. Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie W; DStandards Practice Task Force, American Society of Colon and Rectal Surgeons. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2008;81(1): 2-9
26. Deniaud-Alexandre E, Touboul E, Tiret E, et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003;56(5): 1259-1273
27. Mullen JT, Rodriguez-Bigas MA, Chang GJ, et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 2007;14(2):478-483
28. Roohipour R, Patil S, Goodman KA, et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008;51(2):147-153
29. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005;92(5): 605-614
30. Akbari RP, Paty PB, Guillem JG, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004;47(7):1136-1144
31. Papaconstantinou HT, Bullard KM, Rothenberger DA, Madoff RD. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity. Colorectal Dis 2006;8(2):124-129
32. Nilsson PJ, Svensson C, Goldman S, Ljungqvist O, Glimelius B. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 2005; 61(1):92-102
33. Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92(1):77-84
34. Swan MC, Furniss D, Cassell OCS. Surgical management of metastatic inguinal lymphadenopathy. BMJ 2004;329 (7477): 1272-1276
35. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008;51(1):73-81
36. Blazy A, Hennequin C, Gornet JM, et al. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005;48(6):1176-1181
37. Place RJ, Gregorcyk SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001;44(4): 506-512
38. Stadler RF, Gregorcyk SG, Euhus DM, Place RJ, Huber PJ, Simmang CL. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 2004;47(8):1305-1309